Stericycle, Inc. (NASDAQ:SRCL) Receives $74.00 Consensus Price Target from Analysts

Stericycle, Inc. (NASDAQ:SRCL) has been assigned a consensus rating of “Hold” from the six research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $74.00.

Several equities research analysts recently commented on SRCL shares. Truist Financial boosted their price objective on shares of Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research report on Tuesday, June 4th. StockNews.com assumed coverage on shares of Stericycle in a report on Monday. They issued a “hold” rating on the stock. Royal Bank of Canada restated a “sector perform” rating and issued a $62.00 target price (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Robert W. Baird reduced their target price on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, April 26th. Finally, Keefe, Bruyette & Woods upped their target price on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a report on Tuesday, June 4th.

Stericycle Stock Performance

Shares of SRCL opened at $58.27 on Wednesday. The stock has a market capitalization of $5.41 billion, a P/E ratio of -264.86, a P/E/G ratio of 3.14 and a beta of 1.11. Stericycle has a 1 year low of $37.78 and a 1 year high of $59.45. The company’s fifty day moving average is $54.05 and its two-hundred day moving average is $51.39. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.11 and a current ratio of 1.11.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 EPS for the quarter, topping the consensus estimate of $0.54 by $0.03. The company had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The business’s revenue was down 2.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.49 EPS. On average, sell-side analysts predict that Stericycle will post 2.32 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of SRCL. Clearstead Trust LLC acquired a new position in shares of Stericycle during the 1st quarter valued at about $25,000. Principal Securities Inc. acquired a new stake in Stericycle during the 4th quarter worth approximately $41,000. GAMMA Investing LLC increased its position in Stericycle by 170.9% during the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after purchasing an additional 516 shares in the last quarter. TFO Wealth Partners LLC increased its position in Stericycle by 22,325.0% during the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after purchasing an additional 893 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new stake in Stericycle during the 1st quarter worth approximately $44,000. Institutional investors and hedge funds own 98.82% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.